| |
| |
|
| Insider
Information: |
Xu Stella |
| Relationship: |
|
| City: |
Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
5,823,230 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$614,493 |
|
|
| Total
Shares |
5,823,230 |
|
|
| Total
Value |
$614,493 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Armo Biosciences Inc |
ARMO |
Director |
2018-01-30 |
0 |
2018-06-22 |
0 |
Premium* |
|
|
Nextcure, Inc. |
NXTC |
Director |
2019-05-13 |
0 |
2019-05-13 |
1,103,570 |
Premium* |
|
|
Design Therapeutics, Inc. |
DSGN |
Director |
2021-03-30 |
0 |
2022-03-22 |
4,139,950 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
|
2021-06-25 |
0 |
2021-06-25 |
579,710 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DSGN |
Design Therapeutics, Inc. |
Director |
– • – |
2022-03-22 |
4 |
S |
$18.63 |
$27,105 |
I/I |
(1,455) |
4,129,950 |
0 |
- |
|
| DSGN |
Design Therapeutics, Inc. |
Director |
– • – |
2022-03-21 |
4 |
S |
$19.01 |
$456,240 |
I/I |
(24,000) |
4,131,405 |
0 |
- |
|
| DSGN |
Design Therapeutics, Inc. |
Director |
– • – |
2022-03-18 |
4 |
S |
$19.04 |
$10,782,852 |
I/I |
(565,425) |
4,155,405 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
|
• • – |
2021-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
579,710 |
579,710 |
0 |
- |
|
| DSGN |
Design Therapeutics, Inc. |
Director |
– • • |
2021-03-30 |
4 |
B |
$20.00 |
$200,000 |
I/I |
10,000 |
4,730,830 |
2.25 |
- |
|
| DSGN |
Design Therapeutics, Inc. |
Director |
– • • |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,720,830 |
4,720,830 |
0 |
- |
|
| NXTC |
Nextcure, Inc. |
Director |
– • – |
2019-05-13 |
4 |
B |
$15.00 |
$1,875,000 |
I/I |
125,000 |
1,103,570 |
2.1 |
- |
|
| NXTC |
Nextcure, Inc. |
Director |
– • – |
2019-05-13 |
4 |
A |
$0.00 |
$0 |
I/I |
978,570 |
978,570 |
0 |
- |
|
| ARMO |
Armo Biosciences Inc |
Director |
– • – |
2018-06-22 |
4 |
D |
$50.00 |
$20,245,000 |
I/I |
(404,900) |
0 |
0 |
- |
|
| ARMO |
Armo Biosciences Inc |
Director |
– • – |
2018-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
404,900 |
404,900 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
